About
Douglas J. Jolly is the founder and Chief Advisor at Abintus Bio, Inc. and works as a private consultant at Private Client Consultancy. Over roughly three decades in biotechnology, he has held senior roles at Viagene, Chiron Corporation, Oxford BioMedica, Advantagene, and Tocagen, where he advanced the first in vivo application of an integrating retrovirus through global Phase 3 trials. He has published more than 125 scientific articles and is an inventor on over 50 issued patents.
Founder at Abintus Bio
Intro paths
→
In turn, Douglas can intro founders to Abintus Bio's investors below.
Abintus Bio's investors · 1
Experience
- Private Client ConsultancyPrivate Consultantcurrent2023 — present
- PrivateComsultant2023 — 2025San Diego, USA
- Abintus Bio, Inc.Founder & Chief Advisor2020 — 2025San Diego, California, United States
- Tocagen Inc.Co-Founder, Executive VP, Research & Pharmaceutical Development2007 — 2020San Diego CA
- AdvantageneCo-founder, President & COO2004 — 2008Greater San Diego Area & Boston MA
- Oxford Biomedica, BioMedica USACEO2001 — 2004
- Chiron CorporationVP Scientific Affairs CGT1995 — 2001
- Viagene IncCo-Founder & VP Research1988 — 1995
Skills & more
MentoringNegotiationStrategic Planning1LeadershipIND4Manufacturing Operations ManagementClinical ResearchPharmaceuticalsMarketing StrategyBusiness StrategyExpert AdvisorStrategic Vision
+12 more
Executive TeamBoard of DirectorsPresentation SkillsProgram ManagementNonprofit OrganizationsGrowth StrategiesCoachingBusiness PlanningPK/PDStrategynContract Negotiation hired >IntellectuaL Property ManagementLanguages English · French
- 1% Leadership: How Tiny Changes Forge Great Leaders — LinkedIn
From Douglas's professional profile.
Frequently asked questions
- Who is Douglas J. Jolly?
- Douglas J. Jolly is the founder and Chief Advisor at Abintus Bio, Inc. and works as a private consultant at Private Client Consultancy. Over roughly three decades in biotechnology, he has held senior roles at Viagene, Chiron Corporation, Oxford BioMedica, Advantagene, and Tocagen, where he advanced the first in vivo application of an integrating retrovirus through global Phase 3 trials. He has published more than 125 scientific articles and is an inventor on over 50 issued patents.
- Where does Douglas J. Jolly work?
- Douglas J. Jolly is Founder of Abintus Bio.
- What companies did Douglas J. Jolly found?
- Douglas J. Jolly founded Abintus Bio.
- Where did Douglas J. Jolly go to school?
- Douglas J. Jolly studied at Harvard Medical School (Post-Doc); INSERM (Associate Professor); University of Glasgow (Ph.D., Biochemistry).
Are you in our directory? — or find your own page and tap it there to see your paths to every investor.
Founder mafias
UC San Diego mafia234
Also came through, then founded or led a company.
Elad GilBAFounded Brain Co. +1Chester NgBSFounded DivXPhillip SamayoaPhDFounded Generation Bio +2Wendy JohanssonCognitive ScienceFounded Misaludhealth +2Elizabeth A. MullerBachelorsFounded Deep Isolation +2Sean AinsworthB.S.Founded RetroSense Therapeutics +1
+ 227 more
Harvard Medical School mafia110
Also came through, then founded or led a company.
George ChurchFounded Editas Medicine +5Sangeeta N. BhatiaDoctor of Medicine (MD)Founded Port Therapeutics +3Andrey ZarurClinical ImmunologyFounded GreenLight Pandemic Response +3Howard ChangM.D.Founded Accent Therapeutics +3Michael TolentinoResidencyFounded Aviceda Therapeutics +2Venky SoundararajanResearch Fellowship in GeneticsFounded nference +2
+ 103 more
University of Glasgow mafia30
Also came through, then founded or led a company.
Andrew AntosExchangeFounded Klarity +1Aart de GeusHonorary PhDFounded Synopsys +1Michel DetheuxPost docFounded iTeos Therapeutics +1Rod MacGregorB. Sc.Founded GlassPoint Solar +1Donald McClymontM.EngFounded indie Semiconductor +1Robbie Th'ngBSc (Hons)Founded Unusual
+ 23 more
Weizmann Institute of Science mafia23
Also came through, then founded or led a company.
Valerian NakaarM.Sc.Founded Carogen Corporaton +1Yaron DanielyPost-DocFounded YissumPete FlintInternational Summer Science SchoolFounded Signal NFXMaya Ben DrorMinerva School on AlternativeFounded ComplexChaosTal ShapiraM.ScFounded Triple WAsaf ZsviranDoctor of Philosophy (Ph.D.)Founded C2i Genomics
.jpg)
+ 16 more
Same school
Also attended Harvard Medical School243
Niko BonatsosFounder and Managing Partner of VerdictAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
.png)
+ 237 more
Also attended University of Glasgow102
Andreas SchropferHead of Finance at Brighteye VenturesSarah MandersonLegal Director at Hoxton VenturesKelsey BolanderAssociate — Business Ops & Partner Support at Energize VenturesRob DesboroughGeneral Partner and Chair of Seraphim Space Accelerator at Seraphim SpaceAida KhalilProgramme Associate at Seraphim SpaceNatalie JohnstonInvestment Principal at 4BIO Capital
+ 96 more
Also attended UC San Diego433
Elad GilSolo general partner investing through Gil CapitalMark SusterManaging Partner at Upfront VenturesChester NgGeneral Partner at AtomicBirgitteInvestor at InvestinorHouman HaghighiPartner, Business & Corporate Development at Menlo VenturesFreya Svedberg-KeatingInvestor at Medicxi
+ 427 more
Shared employers
Also worked at Chiron Corporation19
Annalisa D'AndreaVenture Partner at Longwood FundAlexia PerouseManaging Partner and CEO at iBionextDion MadsenPartner at Amplitude Venture CapitalLisa WisniewskiManaging Director at Global BioAccess FundBeckie RobertsonVenture Advisor at Intuitive VenturesLisa Wisniewski, PhDManaging Director at Global BioAccess Fund
+ 13 more